Beth Pegram

Beth Pegram has extensive experience in the pharmaceutical industry, primarily in the role of Director National Accounts. Beth is currently employed at Travere Therapeutics since 2022. Previously, they held similar positions at Astellas Gene Therapies from 2021 to 2022, AveXis, Inc. from 2018 to 2021, and Intarcia Therapeutics, Inc. from 2017 to 2018. Prior to that, they worked at Vertex Pharmaceuticals as a Regional Account Manager, focusing on National and Regional Accounts from 2011 to 2017. Beth's career began at Novartis in 2004 as an Executive Respiratory CF Sales Specialist, and they remained in that role until 2011.

Beth Pegram attended Campbell University, Lundy-Fetterman School of Business, starting in 1992. Beth studied Communications & Marketing with a focus on Pharmaceutical Marketing and Management. The end year of their education is not provided.